NASDAQ · Analyst Forecast

Larimar Therapeutics, Inc. (LRMR) Stock Forecast & Price Target

$2.99 NASDAQ: LRMR Market Cap $310.61M

Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Larimar Therapeutics, Inc. (LRMR), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Larimar Therapeutics, Inc., the average estimate for 2030 earnings per share is $1.56; with published estimates ranging from −$0.03 to $4.96; 8 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$2.99
Consensus targetThe average of the price targets analysts have published.$8.00
Median targetThe middle target, less affected by a single outlier.$8.00
Highest targetThe most optimistic published target.$11.00
Lowest targetThe most pessimistic published target.$5.00
Difference from priceHow far the consensus target sits from today’s price.+167.6%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$0$0$06
2026$498,828$2.32M$6.21M7
2027$8.72M$41.74M$80.93M8
2028$29.10M$130.36M$277.48M7
2029$70.20M$326.03M$874.14M3
2030$104.31M$484.45M$1.30B5

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$2.18−$1.95−$1.576
2026−$1.40−$1.38−$1.367
2027−$1.50−$1.18−$0.768
2028−$1.01−$0.53−$0.097
2029−$0.01$0.52$1.663
2030−$0.03$1.56$4.965

Larimar Therapeutics, Inc. (LRMR) forecast — frequently asked questions

What is the analyst price target for Larimar Therapeutics, Inc.?

Analysts covering Larimar Therapeutics, Inc. (LRMR) have a consensus price target of $8.00, 167.6% above the current price of $2.99. Published targets range from $5.00 to $11.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Larimar Therapeutics, Inc.'s earnings?

The average analyst estimate for Larimar Therapeutics, Inc. (LRMR) earnings per share in 2030 is 1.56, with individual estimates between -0.03 and 4.96.

How much revenue is Larimar Therapeutics, Inc. expected to make?

Analysts forecast Larimar Therapeutics, Inc. (LRMR) revenue of $484.45M in 2030, based on 5 published estimates.

How many analysts cover LRMR?

8 analysts contribute estimates for Larimar Therapeutics, Inc. (LRMR). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.